Which brain structure is primarily affected by atrophy in Huntington's disease?

Which brain structure is primarily affected by atrophy in Huntington's disease?

• A. Basal ganglia
• B. Cerebellum
• C. Midbrain
• D. Thalamus

Answer: (A)

Huntington's disease is a neurodegenerative disorder characterized by the progressive degeneration of neurons, particularly within the basal ganglia. The basal ganglia are a group of nuclei in the brain that are crucial for coordinating movement, controlling voluntary motor activities, and regulating various cognitive and emotional functions. Atrophy of the striatum, which is part of the basal ganglia, is particularly significant in individuals with Huntington's disease. This atrophy leads to the hallmark symptoms of the condition, including involuntary movements (chorea), psychiatric disturbances, and cognitive decline. While the other brain structures listed—cerebellum, midbrain, and thalamus—can be affected in various neurological conditions, they are not primarily associated with the pathological changes seen in Huntington's disease. The distinct vulnerability of the basal ganglia to atrophy in this disorder is what makes it the most relevant choice in this context.

Huntington's disease is a neurodegenerative disorder characterized by the progressive degeneration of neurons, particularly within the basal ganglia. The basal ganglia are a group of nuclei in the brain that are crucial for coordinating movement, controlling voluntary motor activities, and regulating various cognitive and emotional functions. Atrophy of the striatum, which is part of the basal ganglia, is particularly significant in individuals with Huntington's disease. This atrophy leads to the hallmark symptoms of the condition, including involuntary movements (chorea), psychiatric disturbances, and cognitive decline.

While the other brain structures listed—cerebellum, midbrain, and thalamus—can be affected in various neurological conditions, they are not primarily associated with the pathological changes seen in Huntington's disease. The distinct vulnerability of the basal ganglia to atrophy in this disorder is what makes it the most relevant choice in this context.